Researcher

Ying Li

Qingdao University

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials

Frontiers in Immunology

A narrative review summarizing mechanistic evidence and preclinical/early translational data on the CCL2–CCR2 axis in lung cancer, without reporting original clinical trial results or definitive clinical outcomes.

Hypothesis-GeneratingJia Ma Jianping Bi Guoliang Pi

SEP 4, 2026 · JOURNAL ARTICLE

Adverse childhood experiences and chronic liver diseases: Dose-response, type-specific associations, and mediation analyses

Acta Psychologica

Large prospective cohort study with 107,363 participants, hard clinical endpoints (CLD diagnoses from linked medical records), clear dose-response relationships, and rigorous mediation analysis; robust but observational design limits causal inference.

Strong EvidenceJinling Tang Shanshan Wu Ying Li

Reported

Sample size107363

CLD cases1888

CLD incidence proportion1.8%

AUG 8, 2026 · JOURNAL ARTICLE

Neural regulation in lung cancer: from mechanisms to new therapeutic perspectives

Clinical and Experimental Medicine

This is a narrative review synthesizing mechanistic evidence about neural regulation in lung cancer, raising questions about therapeutic potential rather than reporting original empirical results or clinical outcomes.

Hypothesis-GeneratingYongxue Li Yiming Han Cancer Cells and Metastasis